278 related articles for article (PubMed ID: 20131930)
1. Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery.
Chlupáč J; Filová E; Bačáková L
Physiol Res; 2009; 58 Suppl 2():S119-S140. PubMed ID: 20131930
[TBL] [Abstract][Full Text] [Related]
2. [Vascular prostheses: 50 years of advancement from synthetic towards tissue engineering and cell therapy].
Chlupác J; Filová E; Bacáková L
Rozhl Chir; 2010 Jan; 89(1):85-94. PubMed ID: 21351411
[TBL] [Abstract][Full Text] [Related]
3. Considerations in the Development of Small-Diameter Vascular Graft as an Alternative for Bypass and Reconstructive Surgeries: A Review.
Obiweluozor FO; Emechebe GA; Kim DW; Cho HJ; Park CH; Kim CS; Jeong IS
Cardiovasc Eng Technol; 2020 Oct; 11(5):495-521. PubMed ID: 32812139
[TBL] [Abstract][Full Text] [Related]
4. The applications of heparin in vascular tissue engineering.
Aslani S; Kabiri M; HosseinZadeh S; Hanaee-Ahvaz H; Taherzadeh ES; Soleimani M
Microvasc Res; 2020 Sep; 131():104027. PubMed ID: 32505610
[TBL] [Abstract][Full Text] [Related]
5. Current status on vascular substitutes.
Lejay A; Vento V; Kuntz S; Steinmetz L; Georg Y; Thaveau F; Heim F; Chakfé N
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):538-543. PubMed ID: 32885928
[TBL] [Abstract][Full Text] [Related]
6. Advancing tissue-engineered vascular grafts via their endothelialization and mechanical conditioning.
Antonyshyn JA; D'''''Costa KA; Santerre JP
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):555-576. PubMed ID: 32909708
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
8. Sustained Thromboresistant Bioactivity with Reduced Intimal Hyperplasia of Heparin-Bonded Polytetrafluoroethylene Propaten Graft in a Chronic Canine Femoral Artery Bypass Model.
Freeman J; Chen A; Weinberg RJ; Okada T; Chen C; Lin PH
Ann Vasc Surg; 2018 May; 49():295-303. PubMed ID: 29197605
[TBL] [Abstract][Full Text] [Related]
9. New biological solutions for hemodialysis access.
Peck MK; Dusserre N; Zagalski K; Garrido SA; Wystrychowski W; Glickman MH; Chronos NA; Cierpka L; L'Heureux N; McAllister TN
J Vasc Access; 2011; 12(3):185-92. PubMed ID: 21404221
[TBL] [Abstract][Full Text] [Related]
10. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
11. New prostheses for use in bypass grafts with special emphasis on polyurethanes.
Tiwari A; Salacinski H; Seifalian AM; Hamilton G
Cardiovasc Surg; 2002 Jun; 10(3):191-7. PubMed ID: 12044423
[TBL] [Abstract][Full Text] [Related]
12. PEPE II--a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylene vascular graft for above and below knee bypass surgery: determinants of patency.
Hugl B; Nevelsteen A; Daenens K; Perez MA; Heider P; Railo M; Schelzig H; Gluecklich B; Balzer K; Vermassen F; De Smit P; Fraedrich G;
J Cardiovasc Surg (Torino); 2009 Apr; 50(2):195-203. PubMed ID: 19329916
[TBL] [Abstract][Full Text] [Related]
13. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
14. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
15. Experimental noninferiority trial of synthetic small-caliber biodegradable versus stable vascular grafts.
Mugnai D; Tille JC; Mrówczyński W; de Valence S; Montet X; Möller M; Walpoth BH
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):400-7.e1. PubMed ID: 23098749
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
17. A clinical commentary on the article "an early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia".
Shenoy S
J Cardiovasc Transl Res; 2011 Oct; 4(5):683-4. PubMed ID: 21842342
[No Abstract] [Full Text] [Related]
18. Patency of the saphenous vein conduit anastomosed to the aortic dacron graft.
Kara I; Koksal C; Boyacioglu K; Ay Y; Yanartas M; Metin Esen A
J Cardiovasc Surg (Torino); 2013 Oct; 54(5):647-52. PubMed ID: 24002395
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic Heparan Sulfate-Like Coated ePTFE Grafts Reduce In-graft Neointimal Hyperplasia in Ovine Carotids.
Wulff B; Stahlhoff S; Vonthein R; Schmidt A; Sigler M; Torsello GB; Herten M
Ann Vasc Surg; 2017 Apr; 40():274-284. PubMed ID: 28163179
[TBL] [Abstract][Full Text] [Related]
20. [Vascular graft prosthesis].
Chakfé N; Dieval F; Thaveau F; Rinckenbach S; Hassani O; Camelot G; Durand B; Kretz JG;
Ann Chir; 2004 Jun; 129(5):301-9. PubMed ID: 15220107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
